Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation. [electronic resource]
Producer: 20190115Description: 1706-1715 p. digitalISSN:- 1745-7254
- Animals
- Berberine -- therapeutic use
- Brain -- pathology
- Brain Edema -- drug therapy
- Down-Regulation
- Glycyrrhizic Acid -- therapeutic use
- HMGB1 Protein -- antagonists & inhibitors
- Infarction, Middle Cerebral Artery -- drug therapy
- Interleukin-1beta -- metabolism
- Interleukin-6 -- metabolism
- Male
- Mice, Inbred C57BL
- NF-kappa B p50 Subunit -- antagonists & inhibitors
- Neuroprotective Agents -- therapeutic use
- Reperfusion Injury -- complications
- Signal Transduction -- drug effects
- Toll-Like Receptor 4 -- genetics
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.